Given their reported association with GIST aggressiveness and unfavorable prognosis, the methylation levels of CDKN2A, PAX3, REC8, and SPP1 were analyzed [19, 20, 21]. The gene discussed is CDKN2A; the disease is gastrointestinal stromal tumor.